Canada Markets closed

Neuronetics, Inc. (STIM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.5000+0.1400 (+5.93%)
At close: 03:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close2.3600
Open2.3600
Bid2.5000 x 1100
Ask2.5100 x 1300
Day's Range2.2750 - 2.5700
52 Week Range1.9800 - 17.9200
Volume85,893
Avg. Volume275,914
Market Cap65.92M
Beta (5Y Monthly)2.35
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Motley Fool

    Neuronetics, Inc. (STIM) Q1 2022 Earnings Call Transcript

    Good morning, and thank you for joining us for Neuronetics' First Quarter 2022 conference call. Joining me on today's call are Neuronetics' president and chief executive officer, Keith Sullivan; and the SVP chief financial officer and treasurer, Steve Furlong. Before we begin, I would like to caution listeners that certain information discussed by management during this conference call will include forward-looking statements covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements related to our business, strategy, financial and revenue guidance, the impact of COVID-19 and other operational issues and metrics.

  • Zacks

    Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates

    Neuronetics (STIM) delivered earnings and revenue surprises of 0% and 7.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Zacks

    Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates

    Glaukos (GKOS) delivered earnings and revenue surprises of 26.92% and 11.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?